Connect with us

Government

AI-Enabled Butterfly Network Lung Tool Receives FDA Clearance

What You Should Know: – Today, Butterfly Network announced it received 510(k) clearance from the FDA for a groundbreaking AI-enabled tool named AI-enabled…

Published

on

This article was originally published by HIT Consultant

What You Should Know:

– Today, Butterfly Network announced it received 510(k) clearance from the FDA for a groundbreaking AI-enabled tool named AI-enabled Auto B-line Counter that will help physicians assess adults’ lungs and accelerate providers’ abilities to make informed treatment decisions. Butterfly used data inputs from hundreds of sites across the country to train and develop its AI algorithms, offering potential for a broad and diverse range of age, gender, body mass index, ethnicity, and race.

– With this new tool, providers in just six seconds will be able to quickly detect markers of congestive heart failure, chronic obstructive pulmonary disease, pneumonia and COVID-19. Instead of first being sent for timely x-ray scans and blood tests, patients in ERs and clinics will be able to be quickly scanned by a Butterfly device and receive treatment much sooner.

– The company anticipates that the AI-enabled Auto B-line Counter will launch early summer in the United States.

Psychedelics

Here Are the Champions! Our Top Performing Stories in 2023

It has been quite a year – not just for the psychedelic industry, but also for humanity as a whole. Volatile might not be the most elegant word for it,…

Continue Reading
Medtech

AI can already diagnose depression better than a doctor and tell you which treatment is best

Artificial intelligence (AI) shows great promise in revolutionizing the diagnosis and treatment of depression, offering more accurate diagnoses and predicting…

Continue Reading
Government

Scientists use organoid model to identify potential new pancreatic cancer treatment

A drug screening system that models cancers using lab-grown tissues called organoids has helped uncover a promising target for future pancreatic cancer…

Continue Reading

Trending